Paramedic Papers

Home Paediatrics Paediatric IV ketamine sedation very safe

Paediatrics

Paediatric IV ketamine sedation very safe

Systematic Review of Pediatric Ketamine in Emergency Department Procedural Sedation: Frequency and Predictors of Adverse Events
Annals of Emergency Medicine · Added 19 September 2026

Systematic review of 20 studies covering 67,871 children having IV ketamine procedural sedation in EDs — no deaths or permanent adverse outcomes, sentinel events pooled at about 1 in 11,558 sedations, serious adverse events 0.34%, with age ≥10, upper respiratory infection and opioid co-administration modest predictors while ASA status and benzodiazepine co-administration were not.

Study type
Systematic review
Design
Systematic review of studies with ≥250 children
Participants
58,752 children receiving IV ketamine in EDs across 20 studies
Main finding
No deaths or permanent adverse outcomes; pooled sentinel events 0.0041% (~1 in 24,390 sedations); serious adverse events 0.33%; predictors of serious events were age ≥10 years, upper respiratory infection and co-administered opioids.
Caveat
Heterogeneity across studies; ED (not prehospital) setting; rare-event estimates imprecise.
Bottom line
Supports current practice

Why it matters in Australia (Medium relevance). ED-based procedural sedation rather than prehospital practice, but reassuring safety data for a heavily used AP formulary drug

Learning goal

Strengthen my risk assessment for paediatric ketamine sedation by recognising which children face higher adverse event risk.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Paediatrics